Radiochemistry and Innovative Uses of Radioisotopes

Join us for a meeting to continue advancing programs in Radiochemistry and Innovative uses of Radioisotopes at MSU, Henry Ford and beyond. Featauring a series of short presentations that aim to introduce the full breadth of radiochemistry topics being addressed at MSU and identify areas of future growth, the aim of this meeting will be to better understand our strengths in radiochemistry, build our community of scientists in this area by examining our proposed recruitment efforts, and lay out plans for training grants and program project grants that will support these efforts. Registration is limited, please register by April 10. 

Speakers
Luke Augustine, Vice President, New Business Development, Nuclear and Precision Health Solutions, Cardinal Health
Norman J. Beauchamp Jr., Executive Vice President Health Sciences
Carolina de Aguiar Ferreira, Assistant Professor, Departments of Radiology, Pharmacology & Toxicology, and Biomedical Engineering
Mark DeLano, Chair, Department of Radiology; Director, Division of Radiology and Biomedical Imaging, Department of Radiology, MSU College of Human Medicine
Matt DeLong, Vice President, Radiopharmacy, BAMF Health
Katharina Domnanich, Assistant Professor, Nuclear Chemistry, Department of Chemistry
Philip M. Duxbury, Dean, College of Natural Science, Professor, Department of Physics & Astronomy
Jinda Fan, Assistant Professor, Radiology and Chemistry, Department of Chemistry
Douglas Gage, Vice President, Office of Research and Innovation
Thomas Glasmacher, Director, FRIB Laboratory
Kevin O'Brien, Division Head, Nuclear Medicine and Molecular Imaging, Henry Ford Health
Thomas O'Halloran, University Foundation Professor of Chemistry, Professor of Microbiology and Molecular Genetics
Kurt Zinn, Professor, Biomedical Engineering and Radiology

Agenda

8:30 Check-in and continental breakfast
9:00 Welcome, Presentations begin

• Welcome and Purpose: Douglas Gage
• Imagining the Future of Medicine at MSU: Norman J. Beauchamp Jr.
• Nuclear Medicine and Theranostics at MSU and Partners: Mark DeLano
• Radiopharmaceutical Clinical Trials at MSU: Kurt Zinn
• Exploring Biological Applications of Radiation: From Imaging the Immune System to Cancer Theranostics: Carolina de Aguiar Ferreira
• Solid Targets C-11 and O-15: Jinda Fan
• Partnerships in Theranostics: Matt DeLong
• Nuclear Medicine at Henry Ford Health: Kevin O'Brien
• Opportunities for High-Purity Radioisotopes from FRIB: Katharina Domnanich
• Uncovering Inorganic Physiology in Health and Disease: Emerging Roles for Radioisotope Tracers: Thomas O'Halloran
• Nuclear Medicine in the Future of Healthcare: Luke Augustine
• Radiochemistry, FRIB, and Natural Science: Philip M. Duxbury
• Facility for Rare Isotope Beams: Thomas Glasmacher

10:10 Break
10:25 Summary and discussion: Thomas Glasmacher
10:45 Idea development and open discussion
11:30 Lunch/visit
12:30 Departure